Results 2,121-2,140 of 3,998 for speaker:Michael Harty

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: Does it involve population health?

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: When will the citizen care plan be available?

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: Okay. I thank Ms Magahy. I call Senator Burke.

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: The Trinity College Dublin team will be coming in soon and I want to give it an equal opportunity to discuss the Sláintecare implementation strategy. If Deputies Louise O'Reilly and Bernard J. Durkan combine their questions, we can allow the Minister to leave.

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: I thank Ms Magahy and the Minister for attending in order to discuss the Sláintecare implementation strategy. I am sure we will meet them again in the medium term. We will suspend briefly to allow the next group of witnesses to take their seats.

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: We are back in public session. In this session we are meeting with representatives from the Centre for Health Policy and Management at Trinity College Dublin to get their views on the Sláintecare implementation strategy. I welcome Dr. Sara Burke, Professor Steve Thomas and Dr. Bridget Johnston. I wish to draw the attention of the witnesses to the fact that by virtue of section 17(2)(l)...

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: I thank Professor Thomas for his opening remarks. Perhaps he could go through the aforementioned slides now.

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: I thank Dr. Johnston. I will ask the same two questions that I put to the Minister when he appeared before us this morning. First, we had a long discussion in the Sláintecare committee about where the Sláintecare implementation office should sit and it has been placed in the Department of Health. We were strongly of the view that it should be placed in the Department of the...

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: I thank Dr. Burke.

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: I thank Dr. Burke very much.

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: Of course it is. I call on Deputy Stephen Donnelly to make his contribution. We will go through the same format of back and forth for seven minutes, if that is okay.

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: I thank Dr. Johnston.

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: I have a point about services for those aged under six years. Nobody is arguing about the expansion of free care services or services at low cost. In the past few years, however, we have seen the expansion of free GP care to those aged under six years - about an extra 240,000 children - persons in receipt of domiciliary care allowance and carer's allowance. At the same time, there was a...

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: I thank Professor Thomas.

Joint Oireachtas Committee on Health: Sláintecare Implementation Strategy: Discussion (3 Oct 2018)

Michael Harty: I thank the Deputy. I also thank Dr. Sara Burke, Dr. Bridget Johnston and Professor Steve Thomas for coming at short notice. I thank them for their input into the Sláintecare process and the analysis of the outturn so far. I am sure we will meet again.

Written Answers — Department of Employment Affairs and Social Protection: Invalidity Pension Appeals (4 Oct 2018)

Michael Harty: 252. To ask the Minister for Employment Affairs and Social Protection when a person (details supplied) in County Clare will receive a response to an appeal for an invalidity pension; and if she will make a statement on the matter. [40575/18]

Financial Resolutions 2019 - Budget Statement 2019 (9 Oct 2018)

Michael Harty: I am very disappointed with the references in the budget to the health service. There is no appreciation of the health reality that faces ordinary people on endless waiting lists that are stretching and increasing year on year. This year, health spending has gone over budget by €700 million and a Supplementary Estimate will have to be introduced to cover it. We will add €1.05...

Financial Resolutions 2019 - Budget Statement 2019 (9 Oct 2018)

Michael Harty: There is no reference in the budget speech to bed capacity, specifically to the delivery of 2,600 beds and in that the delivery of intensive care unit, ICU, beds. The lack of ICU beds in the Irish hospital system is inhibiting the rolling out of scoliosis treatment, for example, as the theatres and doctors are available but there are no ICU beds to allow the children to be cared for after...

Financial Resolutions 2019 - Budget Statement 2019 (9 Oct 2018)

Michael Harty: The fabric of rural society is unravelling. We are losing our post offices and medical services along with our ability to survive. A Programme for a Partnership Government committed to delivering sustainability for our rural post office network but it has failed to do so. I also refer to broadband, which is a major issue in rural Ireland. This Government has been in power since May...

Written Answers — Department of Health: Rare Diseases (9 Oct 2018)

Michael Harty: 344. To ask the Minister for Health the progress of the rare diseases medical product technology review committee; the drugs that have been referred to it by the HSE; the way in which it is scheduling or prioritising the review of each drug; the number of drugs it expects to review in 2018; the timelines associated with reviewing medicines; and if he will make a statement on the matter. [41125/18]